American College of Cardiology (ACC)

The American College of Cardiology (ACC) is the primary U.S. medical society representing the interests of all cardiology subspecialities. The ACC is very active in setting guidelines for cardiac care, lobbying for supportive government policy and reimbursements, clinician education, managing several key cardiovascular registries and advocating for the transformation of cardiovascular care to improve heart health.

Cardiologist begins term as ACC president with an eye on workforce issues, health equity and more
Christopher M. Kramer, MD, is a longtime cardiologist and cardiac imaging specialist. His one-year term as the head of the American College of Cardiology officially began at the end of ACC.25 in Chicago.
Key takeaways from ACC.25: Advances in cardiovascular science
Former American College of Cardiology president Hadley Wilson, MD, executive vice chair of Atrium Health Sanger Heart and Vascular Institute, explains his main takeaway messages from the ACC 2025 late-breaking trials.
New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS
Two separate studies at ACC.25 explored data from the EARLY TAVR trial. One analysis included stroke findings that surprised researchers.
Dapagliflozin improves outcomes for elderly TAVR patients with heart failure
The positive data were presented as part of a late-breaking clinical trial at ACC.25 in Chicago. One cardiologist on stage for the presentation said these findings will impact the way he manages certain TAVR patients.
Plant-based diets may help patients with diabetes, heart disease live longer
Researchers focused on data from nearly 78,000 adults with cardiometabolic disorders, sharing their findings at ACC.25 in Chicago.

New ACC/AHA/SCAI guidance highlights training requirements for interventional cardiologists

The document, which was designed to help guide both interventional cardiology trainees and program directors, was also endorsed by several other industry societies.

ACC urges all interventional cardiologists to use intravascular imaging during PCI

New recommendations from the American College of Cardiology detail how intravascular imaging can help clinicians before, during and after PCI procedures.

High-risk patients ineligible for bypass surgery see ‘profound improvements’ after PCI

High-risk patients with complex CAD who are ineligible for CABG can still see substantial benefits from PCI.

Balloon expansion deployment of an Edwards Lifesciences Sapien 3 transcatheter aortic valve replacement (TAVR) device.

New Jersey hospital performs 4,000th TAVR procedure

Morristown Medical Center first started performing TAVR procedures in 2011 and is now home to one of the largest TAVR programs in the United States.

More than a feeling? Social isolation, loneliness linked to a higher heart failure risk

A new study published in JACC: Heart Failure offers more evidence that a patient's feelings can strongly influence their risk of poor cardiovascular health.

Why are post-TAVR stroke rates higher at comprehensive stroke centers?

One of the more likely reasons is simple: specialty centers have better tools for identifying signs of stroke.

Increased use of CCTA improves CAD outcomes without raising costs

Researchers examined data from nearly 2 million patients, sharing their full findings in JACC: Cardiovascular Imaging.

An example if an implantable cardioverter defibrillator (ICD and its leads connected to the heart. As the leads or deveice wears out, there are recommendations to remove the leads and put in new ones. Image courtesy of RSNA

Infection, heart failure the most common reasons for early mortality after transvenous lead removal

Early mortality specifically related to complications during the TLR procedure was quite rare.

American College of Cardiology (ACC)

Cardiologist begins term as ACC president with an eye on workforce issues, health equity and more

Key takeaways from ACC.25: Advances in cardiovascular science

New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS

Dapagliflozin improves outcomes for elderly TAVR patients with heart failure

Plant-based diets may help patients with diabetes, heart disease live longer